Pazopanib in patients with clear-cell renal cell carcinoma: Seeking the right patient

Camillo Porta, Alessandra Ferrari, Anna M. Czarnecka, Cezary A. Szczylik

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Article number329
JournalFrontiers in Pharmacology
Issue numberJUN
Publication statusPublished - Jun 21 2017


  • Angiogenesis inhibitor
  • Clear cell renal carcinoma
  • Pazopanib
  • Poor risk
  • Real-world

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this